India’s strength in pharmaceuticals is well known--but what’s unfolding now goes beyond low-cost generics and vaccines. With ...

Hyderabad: Vaccine maker Bharat Biotech on Wednesday said its oral cholera vaccine, Hillchol, successfully completed Phase ...

The new bioconjugation site completes the CDMO’s capabilities across payload, linker, and Mab, with onboarding set to start ...

A week after one New Haven-based biotechnology company announced a mass layoff, another has announced plans to cut 40% of its workforce. RallyBio, based at 234 Church St., in New Haven ...

(KRON) — The future of one biotech company on the Peninsula is drastically changing. Unity Biotechnology is laying off its entire workforce, the company announced Monday in a press release.

Pliant Therapeutics, a South San Francisco biotech company developing treatments for fibrosis, is slashing its staff after halting a crucial study over safety concerns. This layoff round arrives ...

The company expects to lay off the majority of its workforce by the end of the second fiscal quarter, according to SEC filings. Mural Oncology is a biotechnology company that focuses on using its ...

Mass firings at the U.S. Food and Drug Administration are particularly risky for small- and mid-cap biotech companies that have innovative treatments in clinical trials but no products on the ...

A biotech company says it has bred three animals with key physical features of the dire wolf — a species that has been extinct for more than 12,000 years. Colossal Biosciences says it used novel ...

AmplifyBio, once one of central Ohio's most promising biotech firms, announced Friday that it has shut down. In a posting on its website, the company said the decision followed months of efforts ...

The staff reductions are slated to occur on May 27. — Roche Molecular Systems, a unit of pharmaceutical company Roche, 108 job cuts in Santa Clara. The layoffs are scheduled for May 28.

23andMe cofounder Linda Avey discussed the company in a LinkedIn post on Wednesday. Avey said the biotech company "lost its way" without product development and "proper governance." 23andMe filed ...